These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1355019)

  • 1. Effects of acute febrile infectious diseases on the oral pharmacokinetics and effects of nitrendipine enantiomers and of bisoprolol.
    Soons PA; Grib C; Breimer DD; Kirch W
    Clin Pharmacokinet; 1992 Sep; 23(3):238-48. PubMed ID: 1355019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and metabolism of bisoprolol enantiomers in humans.
    Horikiri Y; Suzuki T; Mizobe M
    J Pharm Sci; 1998 Mar; 87(3):289-94. PubMed ID: 9523980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective pharmacokinetics of oral and intravenous nitrendipine in healthy male subjects.
    Soons PA; Breimer DD
    Br J Clin Pharmacol; 1991 Jul; 32(1):11-6. PubMed ID: 1888628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereoselective pharmacokinetics of oral felodipine and nitrendipine in healthy subjects: correlation with nifedipine pharmacokinetics.
    Soons PA; Mulders TM; Uchida E; Schoemaker HC; Cohen AF; Breimer DD
    Eur J Clin Pharmacol; 1993; 44(2):163-9. PubMed ID: 8453961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective pharmacokinetics of bisoprolol after intravenous and oral administration in beagle dogs.
    Horikiri Y; Suzuki T; Mizobe M
    J Pharm Sci; 1997 May; 86(5):560-4. PubMed ID: 9145379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grapefruit juice and cimetidine inhibit stereoselective metabolism of nitrendipine in humans.
    Soons PA; Vogels BA; Roosemalen MC; Schoemaker HC; Uchida E; Edgar B; Lundahl J; Cohen AF; Breimer DD
    Clin Pharmacol Ther; 1991 Oct; 50(4):394-403. PubMed ID: 1914375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselective pharmacokinetics of oral nitrendipine in elderly hypertensive patients with normal and impaired renal function.
    Soons PA; Ankermann T; Breimer DD; Kirch W
    Eur J Clin Pharmacol; 1992; 42(4):423-7. PubMed ID: 1516607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single oral dose pharmacokinetics of bisoprolol 10 mg in liver disease.
    Hayes PC; Jenkins D; Vavianos P; Dagap K; Johnston A; Ioannides C; Thomas P; Williams R
    Eur Heart J; 1987 Dec; 8 Suppl M():23-9. PubMed ID: 2897298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The single dose pharmacokinetics of bisoprolol (10 mg) in renal insufficiency: the clinical significance of balanced clearance.
    Payton CD; Fox JG; Pauleau NF; Boulton-Jones JM; Ioannides C; Johnston A; Thomas P
    Eur Heart J; 1987 Dec; 8 Suppl M():15-22. PubMed ID: 2897297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral pharmacokinetics of bisoprolol in resting and exercising healthy volunteers.
    Le Coz F; Sauleman P; Poirier JM; Cuche JL; Midavaine M; Rames A; Lecocq B; Jaillon P
    J Cardiovasc Pharmacol; 1991 Jul; 18(1):28-34. PubMed ID: 1719288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselective metabolism of bisoprolol enantiomers in dogs and humans.
    Horikiri Y; Suzuki T; Mizobe M
    Life Sci; 1998; 63(13):1097-108. PubMed ID: 9763205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of felodipine, nitrendipine and nifedipine in healthy subjects: concentration-effect relationships of racemic drugs and enantiomers.
    Soons PA; Cohen AF; Breimer DD
    Eur J Clin Pharmacol; 1993; 44(2):113-20. PubMed ID: 8453956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetic analysis of bisoprolol.
    Grevel J; Thomas P; Whiting B
    Clin Pharmacokinet; 1989 Jul; 17(1):53-63. PubMed ID: 2568209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of pseudoracemic nitrendipine to elucidate the metabolic steps responsible for stereoselective disposition of nitrendipine enantiomers.
    Mast V; Fischer C; Mikus G; Eichelbaum M
    Br J Clin Pharmacol; 1992 Jan; 33(1):51-9. PubMed ID: 1540491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Casual versus ambulatory twenty-four-hour blood pressure measurement in a comparative study with bisoprolol or nitrendipine.
    Mengden T; Schubert M; Jeck T; Edmonds D; Vetter W
    J Hypertens Suppl; 1990 Sep; 8(4):S91-4. PubMed ID: 1979615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose proportionality of bisoprolol enantiomers in humans after oral administration of the racemate.
    Dutta A; Lanc R; Begg E; Robson R; Sia L; Dukart G; Desjardins R; Yacobi A
    J Clin Pharmacol; 1994 Aug; 34(8):829-36. PubMed ID: 7962671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the pharmacokinetic properties of bisoprolol and carvedilol in healthy dogs.
    Beddies G; Fox PR; Papich MD; Kanikanti VR; Krebber R; Keene BW
    Am J Vet Res; 2008 Dec; 69(12):1659-63. PubMed ID: 19046015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of intravenous bisoprolol in obese and non-obese volunteers.
    Le Jeunne C; Poirier JM; Cheymol G; Ertzbischoff O; Engel F; Hugues FC
    Eur J Clin Pharmacol; 1991; 41(2):171-4. PubMed ID: 1683835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of bisoprolol during repeated oral administration to healthy volunteers and patients with kidney or liver disease.
    Kirch W; Rose I; Demers HG; Leopold G; Pabst J; Ohnhaus EE
    Clin Pharmacokinet; 1987 Aug; 13(2):110-7. PubMed ID: 2887325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Balanced pharmacokinetics and metabolism of bisoprolol.
    Leopold G
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S16-20. PubMed ID: 2439789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.